Infectio Diagnostic Inc.
This article was originally published in Start Up
Current microbial diagnostics take two to three days to identify infectious agents. During that time, patients in hospitals might not receive the appropriate treatment, or might infect others with antibiotic-resistant microbes. Infectio Diagnostic is developing a rapid DNA diagnostic that will be able to identify infecious microbes in under an hour.
You may also be interested in...
Physicians and hospitals are concerned about the problem of hospital-acquired infections, as is the US Centers for Disease Control, which has launched a campaign to prevent antimicrobial resistance in health care settings. Start-ups believe they can help, with effective and rapid tests for infectious disease and narrow spectrum antimicrobials targeted to specific pathogens. buhed ehnwhihOntros sion, acarel
Despite a couple of setbacks during Q2, Amneal has sustained continual growth across its business, particularly in the injectables space.
Quarterly ups and down notwithstanding, Dr Reddy’s signals continuing US launch momentum, with its generic Revlimid, for which the Indian firm claims exclusivity for two strengths, set to hit the market next month. “Low competition” assets, especially injectables, also continue to be on the deal-making radar in the US.